التفاصيل البيبلوغرافية
| العنوان: |
MO01.18 An indirect Comparison of Pembrolizumab+Chemo vs Ipilimumab+Nivolumab as First-Line Therapies in Patients with PD-L1 TPS≥1% Metastatic NSCLC |
| المؤلفون: |
Thomas Burke, A. Frederickson, Bilal Piperdi, K. Vandormael, Ralph P. Insinga, C. Kalyvas, Balazs Halmos |
| المصدر: |
Journal of Thoracic Oncology. 16:S23 |
| بيانات النشر: |
Elsevier BV, 2021. |
| سنة النشر: |
2021 |
| مصطلحات موضوعية: |
Pulmonary and Respiratory Medicine, Oncology, medicine.medical_specialty, biology, business.industry, First line, Ipilimumab, Pembrolizumab, Indirect comparison, Internal medicine, PD-L1, medicine, biology.protein, In patient, Nivolumab, business, medicine.drug |
| تدمد: |
1556-0864 |
| URL الوصول: |
https://explore.openaire.eu/search/publication?articleId=doi_________::b2f49b91edf4b74f9a619119d6cd2c41
https://doi.org/10.1016/j.jtho.2020.10.066 |
| حقوق: |
OPEN |
| رقم الأكسشن: |
edsair.doi...........b2f49b91edf4b74f9a619119d6cd2c41 |
| قاعدة البيانات: |
OpenAIRE |
